
Rapid Micro Biosystems Inc
RPID · NASDAQ · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Robert G. Spignesi Jr.
- Employees171
- Headquarters25 Hartwell Avenue, Lexington, MA, United States, 02421, USA
- Websitehttps://www.rapidmicrobio.com
Leadership
- Mr. Robert G. Spignesi Jr.CEO, President, COO & Director · b. 1970
- Mr. Sean M. Wirtjes CPAChief Financial Officer · b. 1969
- Mr. Michael Beaulieu C.F.A.Vice President of Investor Relations & Corporate Communications
- Mr. James XuSenior VP of Legal & Secretary
- Ms. Katherine AtkinsonSenior VP of Global Sales & Marketing
- Ms. Julie JarvieSenior VP of Human Resources
- Mr. Chris RobinsonSenior Vice President of Operations
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy3
Ownership Breakdown
- Institutions
- 46.13%
- Insiders
- 10.11%
- Retail / Other
- 43.76%
Top Institutional Holders
- Bain Capital Life Sciences Investors, LLC8.43M16.82%
- ABG-WTT Global Life Science Capital Partners GP Ltd1.85M3.68%
- Vanguard Capital Management, LLC982.49K1.96%
- Evernest Financial Advisors LLC506.00K1.01%
- Advent International LP379.79K0.76%
- Essex Investment Management Company, LLC362.70K0.72%
- SEI Investments Co284.82K0.57%
- Geode Capital Management, LLC247.18K0.49%
- Millennium Management LLC236.60K0.47%
- Susquehanna International Group, LLP212.11K0.42%
- BlackRock Inc157.23K0.31%
- Jane Street Group LLC132.93K0.27%
- Renaissance Technologies Corp126.62K0.25%
- 683 Capital Management LLC120.77K0.24%
- Legato Capital Management LLC119.53K0.24%
- Vanguard Fiduciary Trust Co109.71K0.22%
- Dimensional Fund Advisors, Inc.104.19K0.21%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest750.98K1.50%
- iShares Micro-Cap ETF111.39K0.22%
- Fidelity Extended Market Index103.38K0.21%
Stock Splits
- Oct 29, 20101:30